- Home
- News
- Treatment & Care
- HIV Worldwide
- Living with HIV
- Preventing HIV
- Organisations
- HIV Basics
- About Us
- Recent news headlines
- New position with NAM and HATIP
- Are you translating or adapting our materials?
feedback
Give us your views on our work
New position with NAM and HATIP
Editor/writer, materials for healthcare workers and community-based organisation staff in resource-limited settings
Reporting to: Senior Editor
The role:
NAM is a dynamic and forward thinking charity based in London. It is one of the world's pre-eminent sources of independent, accurate, evidence-based information on HIV/AIDS. NAM has been producing information on HIV/AIDS, and disseminating it across the world, for over 20 years.
NAM has a sizeable audience among healthcare workers and community-based organisation (CBO) staff in resource-limited countries. This new post has been created to support the development of materials and resources for this particular audience. The postholder will work closely with NAM's Senior Editor and the Editor of the acclaimed twice-monthly e-newsletter for healthcare workers and CBO staff in resource-limited settings, HIV & AIDS Treatment in Practice (HATIP).
The role will be responsible for researching and writing clinical reviews covering specific HIV/AIDS related conditions for publication in HATIP. The post holder will lead and develop on-line discussion forums for healthcare audiences designed to promote good practice and peer exchange of successful models of care. S/he will also write news stories about HIV/AIDS treatment and care in developing countries for aidsmap.com.
Please note that to comply with UK employment law, candidates must be nationals of states of the European Economic Area (EEA), Swiss or Turkish nationals or Commonwealth citizens with the right to work in the UK.
To find out more about the job and to download an application form, go to http://www.aidsmap.com/cms1283254.aspx
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.
latest aidsmap news
- HIV/TB epidemic in Eastern Europe a 'public health disaster'
- Low bone mineral density common in HIV-positive men
- Circumcision may protect HIV-negative gay men from syphilis
- HIV 'exposure' from bite forms basis for terrorism charge in US case
- First hint of a hepatitis C vaccine?
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women
- Surviving to die of something else: AIDS is a rare cause of death in old people with HIV
- New EACS guidelines address co-morbidities and diseases of age
- Small case series looks at etravirine during pregnancy
- Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?